首页> 外文期刊>The Journal of trauma >Intrapleural thrombolysis for the management of undrained traumatic hemothorax: a prospective observational study.
【24h】

Intrapleural thrombolysis for the management of undrained traumatic hemothorax: a prospective observational study.

机译:胸腔内溶栓治疗不排水性创伤性血胸:一项前瞻性观察研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Tube thoracostomy is usually sufficient treatment for traumatic hemothorax. Occasionally, significant residual collections remain undrained. Open thoracotomy and video-assisted thoracoscopic surgery (VATS) have been used to manage undrained traumatic hemothoraces (UTHs). Both techniques are invasive and harbor risks. More recently, intrapleural administration of thrombolytic agents (streptokinase and urokinase) has been reported as an effective nonoperative treatment of residual collections caused by a variety of diseases. The role of intrapleural thrombolysis (IT) for the treatment of an UTH is inadequately explored. METHODS: Patients with an UTH, defined as more than 300 mL of intrathoracic blood estimated by computed tomographic scan on the third day after chest tube insertion, were followed prospectively for 16 months. IT was instituted according to a standardized protocol using streptokinase or urokinase. IT effectiveness, defined by the incidence of successful resolution of the UTH, and IT safety, defined by the incidence of uncomplicated therapy, was calculated. RESULTS: Of 203 patients with a traumatic hemothorax, managed by tube thoracostomy, 25 (12.3%) developed an UTH. Successful resolution of the UTH was achieved in 23 (92%) patients within 3.4+/-1.4 days. No bleeding or other significant complications related to IT were recorded. CONCLUSIONS: IT should be the initial treatment of choice for the management of an UTH.
机译:背景:胸腔穿刺术通常是治疗创伤性血胸的足够方法。有时,大量残留物仍不排水。开放式开胸手术和电视胸腔镜手术(VATS)已用于处理不排水的创伤性血统(UTHs)。两种技术都是侵入性的并且具有风险。最近,已报道胸膜内施用溶栓剂(链激酶和尿激酶)是一种有效的非手术治疗由多种疾病引起的残留物的方法。胸膜内溶栓治疗(IT)在治疗UTH中的作用未得到充分探讨。方法:前瞻性随访16个月的UTH患者,其定义为通过计算机断层扫描在胸管插入后第三天估算出的胸腔内血量超过300 mL。根据使用链激酶或尿激酶的标准化方案建立了IT。计算了由UTH成功解决的发生率定义的IT有效性,以及由简单治疗的发生率定义的IT安全性。结果:203例经胸腔穿刺造瘘术治疗的创伤性血胸患者中,有25例(12.3%)发生了UTH。在3.4 +/- 1.4天内,有23名(92%)患者成功解决UTH。没有发现出血或其他与IT相关的重大并发症。结论:IT应该是UTH管理的首选初始治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号